The role of seipin in adipocyte differentiation and lipid droplet formation — ASN Events

The role of seipin in adipocyte differentiation and lipid droplet formation (#28)

H. Rob Yang 1
  1. UNSW, Sydney, NSW, Australia

Seipin, the human Berardinelli-Seip congenital lipodystrophy 2 (BSCL2) gene product, regulates adipocyte differentiation (systemic lipid storage) and lipid droplet (LD) formation (cellular lipid storage). BSCL2 is characterized by almost complete loss of adipose tissue, severe insulin resistance, hypertriglyceridemia and hepatic steatosis. The molecular function of seipin, however, remains to be elucidated. We use a number of model systems to study the role of seipin and its orthologues in lipid storage. Our results suggest that seipin functions in the metabolism of phospholipids, and that seipin deficiency causes accumulation of certain lipid species, such as phosphatidic acid. These accumulated lipids may interfere with PPARgamma function during adipocyte differentiation, causing severe lipodystrophy. These lipid species may also cause morphological changes of LDs in other cell types. Our results therefore provide important insights into adipocyte development, as well as the cellular dynamics of lipid droplets.


Fei W., Du X. and Yang H. (2011) Seipin, adipogenesis and lipid droplets. Trends in Endocrinology and Metabolism, 22: 204-10.

Fei W, Shui G, Zhang Y, Krahmer N, Ferguson C, Kapterian TS, Lin RC, Dawes IW, Brown AJ, Li P, Huang X, Parton RG, Wenk MR, Walther TC and Yang H. (2011) A role for phosphatidic acid in the formation of “supersized” lipid droplets. PLoS Genetics, 7: e1002201.

Cui X, Wang Y, Tang Y, Liu Y, Zhao L, Deng J, Xu G, Peng X, Ju S, Liu, G and Yang H. (2011) Seipin ablation in mice results in severe generalized lipodystrophy. Human Molecular Genetics, 20: 3022-30.

Cui X, Wang Y, Meng L, Fei W, Deng J, Xu G, Peng X, Ju S, Liu G, Zhao L and Yang H. (2012) Overexpression of a short isoform of human seipin/BSCL2 in mouse adipose tissue results in mild lipodystrophy. Am J Physiol Endocrinol Metab. 302 E705-13